Bionik Laboratories Corp. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Bionik Laboratories Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2010 to Q1 2023.
  • Bionik Laboratories Corp. Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2023 was 6.9M shares, a 18.1% increase year-over-year.
  • Bionik Laboratories Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 6.9M shares, a 18.1% increase from 2021.
  • Bionik Laboratories Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 5.84M shares, a 14% increase from 2020.
  • Bionik Laboratories Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 5.13M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 6.9M +1.06M +18.1% Jan 1, 2023 Mar 31, 2023 10-K 2023-06-21
Q4 2022 6.88M +976K +16.5% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-08
Q3 2022 6.88M +1.02M +17.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 6.88M +1.18M +20.7% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-10
Q1 2022 5.84M Jan 1, 2022 Mar 31, 2022 10-K 2023-06-21
Q4 2021 5.9M +777K +15.1% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 5.86M +729K +14.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 5.7M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q4 2020 5.13M Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 5.13M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q4 2018 2.61M +1.93M +285% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-11
Q3 2018 2.46M +1.78M +262% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-13
Q2 2018 258M +161M +166% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q4 2017 679K -95.7M -99.3% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
Q3 2017 679K -85.2M -99.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 97M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q4 2016 96.4M +24M +33.1% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-13
Q3 2016 85.9M +13.5M +18.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q1 2016 72.5M Jan 1, 2016 Mar 31, 2016 10-KT 2016-06-30
Q4 2015 72.4M Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 72.4M +22.7M +45.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q3 2014 49.7M Jul 1, 2014 Sep 30, 2014 10-Q/A 2016-03-17
Q4 2012 4.99M +74.1K +1.51% Oct 1, 2012 Dec 31, 2012 10-K 2013-03-06
Q3 2012 4.99M +88.5K +1.81% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-19
Q2 2012 4.99M +88.5K +1.81% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-07
Q1 2012 4.99M +88.5K +1.81% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-15
Q4 2011 4.91M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-06
Q3 2011 4.9M 0 0% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q2 2011 4.9M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 4.9M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 4.9M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.